Clinical Trial Site

Nagano 390-8621

0 studies enrolling now · 2 studies all time

What they study most

Amyloidosis, Amyloidosis, Hereditary, Transthyretin Amyloidosis

Studies at this site

• HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis) — Completed
• The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran) — Completed